Bicycle Therapeutics (BCYC) Insider Trading & Ownership $7.38 +0.30 (+4.24%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$7.50 +0.13 (+1.69%) As of 08/29/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Bicycle Therapeutics (NASDAQ:BCYC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage22.90%Number OfInsiders Buying(Last 12 Months)1Amount OfInsider Buying(Last 12 Months)$21.23MNumber OfInsiders Selling(Last 12 Months)7Amount OfInsider Selling(Last 12 Months)$751.07K Get BCYC Insider Trade Alerts Want to know when executives and insiders are buying or selling Bicycle Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BCYC Insider Buying and Selling by Quarter Bicycle Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/3/2025Alistair MilnesCOOSell966$7.44$7,187.04 7/3/2025Kevin LeeCEOSell3,193$7.44$23,755.92 7/3/2025Travis Alvin ThompsonCAOSell100$7.44$744.00 7/2/2025Alethia YoungCFOSell204$7.09$1,446.36 7/2/2025Alistair MilnesCOOSell1,149$7.09$8,146.41 7/2/2025Kevin LeeCEOSell2,268$7.09$16,080.12 7/2/2025Travis Alvin ThompsonCAOSell206$7.09$1,460.54 4/2/2025Alethia YoungCFOSell215$8.02$1,724.30 4/2/2025Alistair MilnesCOOSell1,133$8.02$9,086.66 4/2/2025Kevin LeeCEOSell2,237$8.02$17,940.74 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/2/2025Michael Charles Ferguso HannayInsiderSell467$8.02$3,745.34 4/2/2025Michael SkynnerCTOSell814$8.02$6,528.28 4/2/2025Travis Alvin ThompsonCAOSell210$8.02$1,684.20 1/6/2025Travis Alvin ThompsonCAOSell2,686$15.00$40,290.00 1/2/2025Alethia YoungCFOSell1,395$14.09$19,655.55 1/2/2025Alistair MilnesCOOSell4,578$14.09$64,504.02 1/2/2025Kevin LeeCEOSell9,038$14.09$127,345.42 1/2/2025Michael SkynnerCTOSell3,287$14.09$46,313.83 1/2/2025Santiago ArroyoInsiderSell4,943$14.09$69,646.87 1/2/2025Travis Alvin ThompsonCAOSell1,750$14.09$24,657.50 12/16/2024Bros. Advisors Lp BakerDirectorBuy500,000$15.34$7,670,000.00 12/13/2024Bros. Advisors Lp BakerDirectorBuy985,397$13.76$13,559,062.72 11/11/2024Travis Alvin ThompsonCAOSell6,256$25.11$157,088.16 10/3/2024Kevin LeeCEOSell3,212$22.26$71,499.12 10/3/2024Michael Charles Ferguso HannayInsiderSell247$22.26$5,498.22 10/3/2024Michael SkynnerCTOSell972$22.26$21,636.72 10/3/2024Travis Alvin ThompsonCAOSell153$22.26$3,405.78 (Data available from 1/1/2013 forward) BCYC Insider Trading Activity - Frequently Asked Questions Who is on Bicycle Therapeutics' Insider Roster? The list of insiders at Bicycle Therapeutics includes Alethia Young, Alistair Milnes, Bros. Advisors Lp Baker, Kevin Lee, Lee Kalowski, Michael Charles Ferguso Hannay, Michael Skynner, Nicholas Keen, Nigel Crockett, Santiago Arroyo, and Travis Alvin Thompson. Learn more on insiders at BCYC. What percentage of Bicycle Therapeutics stock is owned by insiders? 22.90% of Bicycle Therapeutics stock is owned by insiders. Learn more on BCYC's insider holdings. Which Bicycle Therapeutics insiders have been buying company stock? The following insider purchased BCYC shares in the last 24 months: Bros. Advisors Lp Baker ($21,229,062.72). How much insider buying is happening at Bicycle Therapeutics? Insiders have purchased a total of 1,485,397 BCYC shares in the last 24 months for a total of $21,229,062.72 bought. Which Bicycle Therapeutics insiders have been selling company stock? The following insiders have sold BCYC shares in the last 24 months: Alethia Young ($22,826.21), Alistair Milnes ($97,764.13), Kevin Lee ($576,245.96), Michael Charles Ferguso Hannay ($19,854.93), Michael Skynner ($116,209.26), Nicholas Keen ($24,249.90), Nigel Crockett ($46,252.50), Santiago Arroyo ($69,646.87), and Travis Alvin Thompson ($247,506.02). How much insider selling is happening at Bicycle Therapeutics? Insiders have sold a total of 75,734 Bicycle Therapeutics shares in the last 24 months for a total of $1,220,555.78 sold. Bicycle Therapeutics Key ExecutivesDr. Kevin Lee M.B.A. (Age 56)Ph.D., CEO & Executive Director Compensation: $1.35MSir Gregory Paul Winter CBE (Age 73)FMedsci, FRS, HonFRCP, HonFTSE, Co-Founder & Non-Executive Director Compensation: $57.75kMs. Alethia Rene Young (Age 45)Chief Financial Officer Compensation: $581.69kDr. Santiago Arroyo M.D. (Age 64)Ph.D., Chief Development Officer Compensation: $916.98kDr. Christian HeinisScientific FounderMr. Alistair Milnes (Age 50)Chief Operating Officer Compensation: $796.09k3 recent tradesMr. Travis ThompsonSenior VP, Chief Accounting Officer & Principal Accounting Officer3 recent tradesDr. Michael Skynner B.sc. Ph.d. (Age 55)Ph.D., Chief Technology Officer Compensation: $881.01kDr. Nicholas Keen Ph.D. (Age 56)Chief Scientific Officer Mr. Zafar QadirGeneral Counsel More Insider Trading Tools from MarketBeat Related Companies Arcutis Biotherapeutics Insider Buying Adaptive Biotechnologies Insider Buying CG Oncology Insider Buying ANI Pharmaceuticals Insider Buying Vericel Insider Buying Beam Therapeutics Insider Buying Dyne Therapeutics Insider Buying Apogee Therapeutics Insider Buying Twist Bioscience Insider Buying Travere Therapeutics Insider Buying Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Costco Faces Downgrades, Death Cross, Insider SellingReynolds Consumer Products Stock Price: Insiders Signal a BottomBuy, Sell, or Hold? Insiders Pile Into These 3 Healthcare StocksInsiders Trade Millions in NVIDIA-Linked Navitas, Hims, & Shift45 Stocks Insiders Are Selling That Analysts Say Buy This page (NASDAQ:BCYC) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredNew law could create $3.7 trillion tsunami.During a meeting in Washington D.C., Jeff Brown discovered a bold initiative. He calls it “President Trump’...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bicycle Therapeutics PLC Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Bicycle Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BCYC Stock Alerts